InvestorsHub Logo
Followers 0
Posts 3727
Boards Moderated 0
Alias Born 10/23/2017

Re: JRIII post# 185540

Wednesday, 08/08/2018 12:08:43 PM

Wednesday, August 08, 2018 12:08:43 PM

Post# of 698599
Ok, what i am trying to say is that the blinded data released this year, has not been deemed a failure or success. Only because we don't know the subgroups yet. Several, more educated on the science here, have laid out their charts of the expected breakout of placebo, treatment and crossover that support a successful trial. I happen to believe, based on those analyses, that we will be successful. I believe we will find out that the "predetermined primary endpoint" is irrelevant based on the hold and potential revision of the trial. So, while the expectation of clinical trials is over 90% failure rate, the "preponderance of evidence" starts out skewed in the negative favor. shorts and negative posters thrive on this and make a lot of money until the facts come out, usually 90% in their favor. Based on the blinded data, factual success stories you can read on social media of real life survivors, i don't think it it is irrational. As far as having attorneys run a public company and be in control of the communications? stupid.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News